10 20 30 40 50 60 70 80 2F11 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE 14-NOV-05 2F11
TITLE CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX TITLE 2 WITH ISOBUTYL ETHER MIMETIC INHIBITOR
COMPND MOL_ID: 1; COMPND 2 MOLECULE: SIALIDASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NEU2, CYTOSOLIC SIALIDASE, N-ACETYL-ALPHA- COMPND 5 NEURAMINIDASE 2; COMPND 6 EC: 3.2.1.18; COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-2T
KEYWDS SIALIDASE, NEURAMINIDASE, INFLUENZA VIRUS, DRUG DESIGN, KEYWDS 2 HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR L.M.G.CHAVAS,R.KATO,M.C.MANN,R.J.THOMSON,J.C.DYASON,M.VON AUTHOR 2 ITZSTEIN,P.FUSI,C.TRINGALI,B.VENERANDO,G.TETTAMANTI,E.MONTI, AUTHOR 3 S.WAKATSUKI
REVDAT 2 24-FEB-09 2F11 1 VERSN REVDAT 1 21-NOV-06 2F11 0
JRNL AUTH L.M.G.CHAVAS,R.KATO,M.C.MANN,R.J.THOMSON, JRNL AUTH 2 J.C.DYASON,M.VON ITZSTEIN,P.FUSI,C.TRINGALI, JRNL AUTH 3 B.VENERANDO,G.TETTAMANTI,E.MONTI,S.WAKATSUKI JRNL TITL CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN JRNL TITL 2 COMPLEX WITH ISOBUTYL ETHER MIMETIC INHIBITOR JRNL REF TO BE PUBLISHED JRNL REFN
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.57 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.57 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 62.02 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 10849 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.300 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 573 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2726 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 96 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -21.61600 REMARK 3 B22 (A**2) : 1.54400 REMARK 3 B33 (A**2) : 20.07100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.50 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 43.80 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : IEM_REP.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2F11 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-NOV-05. REMARK 100 THE RCSB ID CODE IS RCSB035319.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-MAR-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUAMTUM 4R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11422 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 62.020 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.10700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.40500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1SNT REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM/POTASSIUM PHOSPHATE, PH 8.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 283K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.18000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.18000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 43.49000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.85000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 43.49000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.85000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 46.18000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 43.49000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 43.85000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 46.18000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 43.49000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 43.85000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE MONOMER IN THE ASYMMETRIC UNIT FORMS THE BIOLOGICAL REMARK 300 MOLECULE
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 42 REMARK 465 SER A 43 REMARK 465 LYS A 44 REMARK 465 LYS A 45 REMARK 465 ASP A 46 REMARK 465 GLU A 47 REMARK 465 HIS A 48 REMARK 465 GLY A 107 REMARK 465 GLN A 108 REMARK 465 VAL A 109 REMARK 465 THR A 110 REMARK 465 GLU A 111 REMARK 465 GLN A 112 REMARK 465 GLN A 113 REMARK 465 GLN A 114 REMARK 465 LEU A 115 REMARK 465 GLN A 116 REMARK 465 THR A 117 REMARK 465 ARG A 118 REMARK 465 HIS A 185 REMARK 465 PRO A 186 REMARK 465 SER A 284 REMARK 465 GLY A 285 REMARK 465 PRO A 286 REMARK 465 GLY A 287 REMARK 465 SER A 288 REMARK 465 PRO A 289 REMARK 465 TYR A 377 REMARK 465 LEU A 378 REMARK 465 PRO A 379 REMARK 465 GLN A 380
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 22 71.10 66.92 REMARK 500 HIS A 132 30.47 70.85 REMARK 500 THR A 143 -80.21 -37.20 REMARK 500 THR A 156 -173.57 -171.17 REMARK 500 CYS A 164 -164.06 -101.09 REMARK 500 ASP A 169 166.60 -46.64 REMARK 500 GLN A 214 171.36 -59.72 REMARK 500 LEU A 217 -138.58 -123.18 REMARK 500 GLN A 256 -88.65 -9.38 REMARK 500 PRO A 268 -33.88 -35.01 REMARK 500 PRO A 269 -38.96 -29.03 REMARK 500 GLN A 270 -0.93 171.06 REMARK 500 HIS A 297 154.27 176.62 REMARK 500 ASP A 306 81.24 63.53 REMARK 500 ALA A 333 -119.35 -121.39 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 400 DISTANCE = 5.42 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 381 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IEM A 382
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SN7 RELATED DB: PDB REMARK 900 HUMAN NEU2 APO-FORM REMARK 900 RELATED ID: 1SO7 RELATED DB: PDB REMARK 900 HUMAN NEU2 SUGAR-INDUCED FORM REMARK 900 RELATED ID: 1VCU RELATED DB: PDB REMARK 900 HUMAN NEU2-DANA COMPLEX REMARK 900 RELATED ID: 2F0Z RELATED DB: PDB REMARK 900 RELATED ID: 2F10 RELATED DB: PDB REMARK 900 RELATED ID: 2F12 RELATED DB: PDB REMARK 900 RELATED ID: 2F13 RELATED DB: PDB REMARK 900 RELATED ID: 2F24 RELATED DB: PDB REMARK 900 RELATED ID: 2F25 RELATED DB: PDB REMARK 900 RELATED ID: 2F26 RELATED DB: PDB REMARK 900 RELATED ID: 2F27 RELATED DB: PDB REMARK 900 RELATED ID: 2F28 RELATED DB: PDB REMARK 900 RELATED ID: 2F29 RELATED DB: PDB
DBREF 2F11 A 1 380 UNP Q9Y3R4 NEUR2_HUMAN 1 380
SEQADV 2F11 GLY A -1 UNP Q9Y3R4 CLONING ARTIFACT SEQADV 2F11 SER A 0 UNP Q9Y3R4 CLONING ARTIFACT
SEQRES 1 A 382 GLY SER MET ALA SER LEU PRO VAL LEU GLN LYS GLU SER SEQRES 2 A 382 VAL PHE GLN SER GLY ALA HIS ALA TYR ARG ILE PRO ALA SEQRES 3 A 382 LEU LEU TYR LEU PRO GLY GLN GLN SER LEU LEU ALA PHE SEQRES 4 A 382 ALA GLU GLN ARG ALA SER LYS LYS ASP GLU HIS ALA GLU SEQRES 5 A 382 LEU ILE VAL LEU ARG ARG GLY ASP TYR ASP ALA PRO THR SEQRES 6 A 382 HIS GLN VAL GLN TRP GLN ALA GLN GLU VAL VAL ALA GLN SEQRES 7 A 382 ALA ARG LEU ASP GLY HIS ARG SER MET ASN PRO CYS PRO SEQRES 8 A 382 LEU TYR ASP ALA GLN THR GLY THR LEU PHE LEU PHE PHE SEQRES 9 A 382 ILE ALA ILE PRO GLY GLN VAL THR GLU GLN GLN GLN LEU SEQRES 10 A 382 GLN THR ARG ALA ASN VAL THR ARG LEU CYS GLN VAL THR SEQRES 11 A 382 SER THR ASP HIS GLY ARG THR TRP SER SER PRO ARG ASP SEQRES 12 A 382 LEU THR ASP ALA ALA ILE GLY PRO ALA TYR ARG GLU TRP SEQRES 13 A 382 SER THR PHE ALA VAL GLY PRO GLY HIS CYS LEU GLN LEU SEQRES 14 A 382 ASN ASP ARG ALA ARG SER LEU VAL VAL PRO ALA TYR ALA SEQRES 15 A 382 TYR ARG LYS LEU HIS PRO ILE GLN ARG PRO ILE PRO SER SEQRES 16 A 382 ALA PHE CYS PHE LEU SER HIS ASP HIS GLY ARG THR TRP SEQRES 17 A 382 ALA ARG GLY HIS PHE VAL ALA GLN ASP THR LEU GLU CYS SEQRES 18 A 382 GLN VAL ALA GLU VAL GLU THR GLY GLU GLN ARG VAL VAL SEQRES 19 A 382 THR LEU ASN ALA ARG SER HIS LEU ARG ALA ARG VAL GLN SEQRES 20 A 382 ALA GLN SER THR ASN ASP GLY LEU ASP PHE GLN GLU SER SEQRES 21 A 382 GLN LEU VAL LYS LYS LEU VAL GLU PRO PRO PRO GLN GLY SEQRES 22 A 382 CYS GLN GLY SER VAL ILE SER PHE PRO SER PRO ARG SER SEQRES 23 A 382 GLY PRO GLY SER PRO ALA GLN TRP LEU LEU TYR THR HIS SEQRES 24 A 382 PRO THR HIS SER TRP GLN ARG ALA ASP LEU GLY ALA TYR SEQRES 25 A 382 LEU ASN PRO ARG PRO PRO ALA PRO GLU ALA TRP SER GLU SEQRES 26 A 382 PRO VAL LEU LEU ALA LYS GLY SER CYS ALA TYR SER ASP SEQRES 27 A 382 LEU GLN SER MET GLY THR GLY PRO ASP GLY SER PRO LEU SEQRES 28 A 382 PHE GLY CYS LEU TYR GLU ALA ASN ASP TYR GLU GLU ILE SEQRES 29 A 382 VAL PHE LEU MET PHE THR LEU LYS GLN ALA PHE PRO ALA SEQRES 30 A 382 GLU TYR LEU PRO GLN
HET PO4 A 381 5 HET IEM A 382 19
HETNAM PO4 PHOSPHATE ION HETNAM IEM 5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H- HETNAM 2 IEM PYRAN-2-CARBOXYLIC ACID
HETSYN IEM ISOBUTYL ETHER MIMETIC
FORMUL 2 PO4 O4 P 3- FORMUL 3 IEM C12 H19 N O6 FORMUL 4 HOH *96(H2 O)
HELIX 1 1 PRO A 29 GLN A 31 5 3 HELIX 2 2 LEU A 142 GLY A 148 1 7 HELIX 3 3 PRO A 149 ARG A 152 5 4 HELIX 4 4 ALA A 317 TRP A 321 5 5 HELIX 5 5 LEU A 369 PHE A 373 1 5
SHEET 1 A 7 GLN A 8 GLN A 14 0 SHEET 2 A 7 GLU A 361 THR A 368 -1 O PHE A 364 N GLU A 10 SHEET 3 A 7 PRO A 348 ALA A 356 -1 N CYS A 352 O LEU A 365 SHEET 4 A 7 VAL A 325 THR A 342 -1 N GLY A 341 O LEU A 349 SHEET 5 A 7 ALA A 305 ASN A 312 -1 N ASP A 306 O GLY A 330 SHEET 6 A 7 GLN A 291 PRO A 298 -1 N TYR A 295 O TYR A 310 SHEET 7 A 7 SER A 275 PRO A 280 -1 N PHE A 279 O TRP A 292 SHEET 1 B 4 ALA A 19 LEU A 28 0 SHEET 2 B 4 SER A 33 ARG A 41 -1 O ARG A 41 N ALA A 19 SHEET 3 B 4 LEU A 51 ASP A 60 -1 O LEU A 51 N GLN A 40 SHEET 4 B 4 GLN A 65 TRP A 68 -1 O GLN A 65 N ASP A 60 SHEET 1 C 4 ALA A 19 LEU A 28 0 SHEET 2 C 4 SER A 33 ARG A 41 -1 O ARG A 41 N ALA A 19 SHEET 3 C 4 LEU A 51 ASP A 60 -1 O LEU A 51 N GLN A 40 SHEET 4 C 4 GLU A 72 VAL A 73 -1 O GLU A 72 N LEU A 54 SHEET 1 D 3 ARG A 83 TYR A 91 0 SHEET 2 D 3 LEU A 98 ILE A 105 -1 O PHE A 99 N LEU A 90 SHEET 3 D 3 ARG A 123 SER A 129 -1 O SER A 129 N LEU A 98 SHEET 1 E 3 TRP A 154 VAL A 159 0 SHEET 2 E 3 LEU A 174 ARG A 182 -1 O TYR A 181 N SER A 155 SHEET 3 E 3 LEU A 165 GLN A 166 -1 N LEU A 165 O VAL A 175 SHEET 1 F 4 TRP A 154 VAL A 159 0 SHEET 2 F 4 LEU A 174 ARG A 182 -1 O TYR A 181 N SER A 155 SHEET 3 F 4 ILE A 191 SER A 199 -1 O ILE A 191 N ARG A 182 SHEET 4 F 4 ALA A 207 ARG A 208 -1 O ALA A 207 N LEU A 198 SHEET 1 G 4 THR A 216 GLU A 225 0 SHEET 2 G 4 ARG A 230 SER A 238 -1 O ARG A 237 N LEU A 217 SHEET 3 G 4 ALA A 242 SER A 248 -1 O VAL A 244 N ALA A 236 SHEET 4 G 4 SER A 258 VAL A 265 -1 O VAL A 261 N ARG A 243
CISPEP 1 GLY A 160 PRO A 161 0 0.27 CISPEP 2 PRO A 315 PRO A 316 0 -0.11
SITE 1 AC1 5 GLN A 14 ALA A 17 HIS A 18 TYR A 20 SITE 2 AC1 5 PRO A 316 SITE 1 AC2 13 ARG A 21 ILE A 22 ARG A 41 MET A 85 SITE 2 AC2 13 ASN A 86 TYR A 181 LEU A 217 ARG A 237 SITE 3 AC2 13 GLN A 270 ARG A 304 TYR A 334 HOH A 385 SITE 4 AC2 13 HOH A 437
CRYST1 86.980 87.700 92.360 90.00 90.00 90.00 C 2 2 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011497 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011403 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010827 0.00000